Immunotherapy combo could open door to liver transplant for more cancer patients
Disease control
Recruiting now
This study tests whether combining immunotherapy with a liver-directed tumor procedure can safely shrink liver cancer (hepatocellular carcinoma) enough to qualify patients for a liver transplant. About 41 adults with advanced liver cancer that currently exceeds transplant criteri…
Phase: PHASE2 • Sponsor: Ju Dong Yang • Aim: Disease control
Last updated Jun 17, 2026 04:14 UTC